These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35856283)

  • 1. Recombinant protein subunit COVID-19 vaccine-induced Guillain-Barré Syndrome in an adolescent: A case report.
    Rohilla R; Kakkar AK; Divyashree K; Mohindra R; Suri V
    Br J Clin Pharmacol; 2023 Feb; 89(2):556-560. PubMed ID: 35856283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post COVID-19 vaccine Guillain-Barré syndrome.
    Khadka B; Khanal K
    J Nepal Health Res Counc; 2022 Mar; 19(4):852-854. PubMed ID: 35615850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
    Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
    Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review.
    Liang H; Cao Y; Zhong W; Ma Z; Liu J; Chen H
    Hum Vaccin Immunother; 2022 Nov; 18(6):2125753. PubMed ID: 36315834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023.
    Jeong YD; Park S; Lee S; Jang W; Park J; Lee K; Lee J; Kang J; Udeh R; Rahmati M; Yeo SG; Smith L; Lee H; Yon DK
    Sci Rep; 2024 Oct; 14(1):24561. PubMed ID: 39427003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
    Das S; Khan RK; Alam SM; Chowdhury NH; Das P
    Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
    Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
    J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
    Hwang BW; Bong JB
    Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
    Sii HL; Ng SH; Wong VF; Law WC
    Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barré syndrome with a thalamic lesion and COVID-19: a case report and discussion on mechanism.
    Geng N; Wang P; Zhang Y
    Front Neurol; 2023; 14():1227505. PubMed ID: 37780717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
    J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
    Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY
    J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
    Acharya B; Kc S; Karki S; Thapa P; Kc P
    Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report.
    Čenščák D; Ungermann L; Štětkářová I; Ehler E
    Acta Medica (Hradec Kralove); 2021; 64(3):183-186. PubMed ID: 34779385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.